Wesper Journal

This in-depth interview with Dr. Atul Malhotra explores the clinical advantages of longitudinal sleep monitoring over single-night studies. The article covers emerging metrics like hypoxic burden, the importance of central sleep apnea detection, racial bias in pulse oximetry, and how GLP-1 therapies like tirzepatide are transforming obstructive sleep apnea treatment. Learn how Wesper’s airflow-based home testing platform delivers accurate, equitable, and evolving care for patients with sleep-disordered breathing.
Continue reading

This article explores how oral GLP-1 therapy, specifically Eli Lilly’s investigational pill orforglipron, may transform the treatment of obstructive sleep apnea (OSA) by targeting one of its primary root causes: obesity. It highlights clinical evidence from GLP-1 drugs like tirzepatide (Zepbound), which has already gained FDA approval for OSA, and examines how weight loss through these therapies significantly improves apnea severity. The article also outlines why the upcoming oral formulation is a game-changer, increasing accessibility and adherence for patients. With obesity, diabetes, and OSA deeply intertwined, GLP-1 therapy may soon play a central role in holistic sleep medicine.
Continue reading

Zepbound (tirzepatide) has received FDA approval for the treatment of obstructive sleep apnea, now included in Medicare coverage to help manage the condition alongside obesity. This approval marks a shift towards a holistic approach, combining medication with real-time monitoring for...
Continue reading

Many people experience immediate mental clarity and reduced brain fog after just one night of using CPAP therapy, as it alleviates airway obstruction and enhances sleep quality. The therapy delivers consistent airway support, leading to improved oxygen levels and restorative...
Continue reading

Discover how Zepbound® (tirzepatide), the first FDA-approved medication for obstructive sleep apnea (OSA) in adults with obesity, is revolutionizing treatment. Combining effective weight management with symptom relief, Zepbound offers a groundbreaking solution that enhances sleep quality, simplifies care pathways, and improves overall health outcomes. Learn more about this transformative advancement in OSA therapy.
Continue reading